APC and colorectal carcinoma: Our Braf models were exclusively generated along with loss of Apc, a condition likely not indicative of human CRC progression as indicated by a recent assessment of human CRC mutational data (Cancer Genome Atlas Network, 2012) and also reflected in our GEMM Braf signature failing to classify BRAF mutant clinical samples.